| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Healthcare Global Enterprises Limited (NSE: HCG)
HCG Technical Analysis
1.5
| As on 26th Apr 2024 HCG SHARE Price closed @ 350.25 and we RECOMMEND Buy for LONG-TERM with Stoploss of 349.74 & Sell for SHORT-TERM with Stoploss of 356.81 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HCGSHARE Price
| Open | 358.95 | Change | Price | % |
| High | 360.00 | 1 Day | -7.05 | -1.97 |
| Low | 347.00 | 1 Week | -18.20 | -4.94 |
| Close | 350.25 | 1 Month | 3.65 | 1.05 |
| Volume | 118985 | 1 Year | 83.35 | 31.23 |
| 52 Week High 375.60 | 52 Week Low 254.65 | ||||
NSE INDIA Most Active Stocks
| IDEA | 14.00 | 0.72% |
| YESBANK | 26.15 | 0.77% |
| IRFC | 158.05 | 5.19% |
| GMRINFRA | 90.75 | 6.58% |
| HUDCO | 228.10 | 12.34% |
| MAHABANK | 67.65 | 3.68% |
| SAIL | 168.55 | 2.18% |
| NHPC | 92.55 | 1.65% |
| TATASTEEL | 165.80 | -1.13% |
| IDFCFIRSTB | 84.80 | 1.68% |
NSE INDIA Top Gainers Stocks
| ROSSELLIND | 468.35 | 20.00% |
| MGEL | 23.25 | 19.85% |
| KIRLOSIND | 5232.65 | 12.84% |
| HUDCO | 228.10 | 12.34% |
| DPABHUSHAN | 1133.45 | 10.42% |
| KECL | 130.60 | 10.30% |
| EXCEL | 0.55 | 10.00% |
| ACL | 98.15 | 9.79% |
| ACL | 98.15 | 9.79% |
| ACL | 98.15 | 9.79% |
NSE INDIA Top Losers Stocks
| LTTS | 4778.10 | -7.81% |
| BAJFINANCE | 6731.20 | -7.73% |
| DBSTOCKBRO | 50.90 | -5.91% |
| COMPUSOFT | 33.95 | -5.56% |
| KSB | 4674.75 | -5.21% |
| KSB | 4674.75 | -5.21% |
| KSB | 4674.75 | -5.21% |
| KSB | 4674.75 | -5.21% |
| KSB | 4674.75 | -5.21% |
| KSB | 4674.75 | -5.21% |
| HCG Daily Charts |
HCG Intraday Charts |
Whats New @ Bazaartrend |
HCG Free Analysis |
|
|
HCG Important Levels Intraday
| RESISTANCE | 375.30 |
| RESISTANCE | 367.27 |
| RESISTANCE | 362.30 |
| RESISTANCE | 357.34 |
| SUPPORT | 343.17 |
| SUPPORT | 338.20 |
| SUPPORT | 333.23 |
| SUPPORT | 325.20 |
HCG Target April 2024
| 4th UP Target | 455.82 |
| 3rd UP Target | 421.31 |
| 2nd UP Target | 399.97 |
| 1st UP Target | 378.64 |
| 1st DOWN Target | 317.76 |
| 2nd DOWN Target | 296.43 |
| 3rd DOWN Target | 275.09 |
| 4th DOWN Target | 240.58 |
HCG Weekly Target
| 4th UP Target | 412.87 |
| 3rd UP Target | 398.62 |
| 2nd UP Target | 389.82 |
| 1st UP Target | 381.01 |
| 1st DOWN Target | 355.89 |
| 2nd DOWN Target | 347.08 |
| 3rd DOWN Target | 338.28 |
| 4th DOWN Target | 324.03 |
HCG Target2024
| 4th UP Target | 634.03 |
| 3rd UP Target | 547.91 |
| 2nd UP Target | 494.68 |
| 1st UP Target | 441.45 |
| 1st DOWN Target | 289.55 |
| 2nd DOWN Target | 236.32 |
| 3rd DOWN Target | 183.09 |
| 4th DOWN Target | 96.97 |
Healthcare Global Enterprises Limited ( NSE INDIA Symbol : HCG )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HCG Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is 60.23 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -59.21 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 105.23 | |
| 10 Day Avg Volume | Traded 16.40 % More then 10 Day Average Volume | ||
HCG Other Details
| Segment | EQ | |
| Market Capital | 28739305472.00 | |
| Sector | Healthcare | |
| Industry | Medical Care Facilities | |
| Offical website | > | |
HCG Address
 |
||
HCG Latest News
HCG Business Profile
HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates four multi-specialty hospitals, including three under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat, as well as one under operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. As of March 31, 2021, it operated 23 cancer centers, including 1 center of excellence in Bengaluru, 2 freestanding diagnostic centers, and 1 day care chemotherapy center across India, as well as 1 cancer center in Africa. The company was founded in 1989 and is based in Bengaluru, India. Address: Unity Building Complex, Bengaluru, India, 560027
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service